|

ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

RECRUITINGSponsored by Hackensack Meridian Health
Actively Recruiting
SponsorHackensack Meridian Health
Started2020-07-12
Est. completion2030-07-12
Locations1 site

Summary

This research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this disease. The purpose of this research study is to create and maintain a research database for patients with ETMR. The database will include information about occurrence rates, patient information, tumor tissue information, and response to treatment. This will help advance our understanding of this rare disease. In addition, this study will include obtaining survival data and evaluating therapeutic response to expert consensus therapy, and procuring patient tumor tissue.

Eligibility

Inclusion Criteria:

1. Patients of any age
2. Patients must have either a histologically confirmed primary intracranial CNS Embryonal Tumor with Multilayer Rosettes (as agreed upon by central review or local pathologist OR
3. Patients must have tumor tissue that possesses C19MC amplification . Central Review is not required (but is strongly recommended) if the patient's tumor does not demonstrate C19MC amplification.
4. Patients may be enrolled at point following diagnosis

Conditions2

CancerEmbryonal Tumor With Multilayered Rosettes

Locations1 site

Hackensack University Medical Center
Hackensack, New Jersey, 07601
Elana Smilow Smilow, MSN551-996-5673elana.smilow@HMHN.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.